Twitter's unique portfolio will help you prepare for your next job.

Published Date: 13 Mar 2023

Among other things, international students seek connections and advice on how to better compete by supporting community groups.

Read Full News

Latest News

Eye Inflammation Tied to Anti-Adalimumab Antibody Formation

Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.

Ralinepag Offers Once Daily Oral Option for PAH

Phase 3 data provide the foundation for a planned New Drug Application.

WHO Chief Says Fast-moving Ebola Epidemic Is Outpacing Response Efforts

The head of the World Health Organization said on Monday that the ⁠fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda was outpacing response ⁠efforts,...

Suspected and Confirmed Measles Deaths Top 500 in Bangladesh

It's one of the country's worst outbreaks in decades.

Experimental Treatments Could Help US Ebola Patient

The U.S. missionary who tested positive for Ebola and is undergoing treatment in a German hospital has been given drugs aimed at reducing disease symptoms after exposure to...

Pill for Obstructive Sleep Apnea Shows Potential

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new strategy to help people with obstructive sleep apnea.

Todays Updates

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Todays Updates

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain.

Abemaciclib Slows Progression of Advanced Liposarcoma

In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Teclistamab Alone Ups Previously Treated Myeloma Survival

In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

A phase 3 trial evaluates the safety and efficacy of an investigational bispecific antibody with chemotherapy compared to standard treatment in advanced squamous NSCLC.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

In an interim analysis of a randomized phase 2 trial, asandeutertinib improved intracranial response and intracranial PFS vs osimertinib in patients with EGFR-mutated NSCLC with brain metastases.

Latest News

Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.

Phase 3 data provide the foundation for a planned New Drug Application.

The head of the World Health Organization said on Monday that the ⁠fast-moving Ebola outbreak in Democratic Republic of Congo and Uganda was outpacing response ⁠efforts,...

It's one of the country's worst outbreaks in decades.

The U.S. missionary who tested positive for Ebola and is undergoing treatment in a German hospital has been given drugs aimed at reducing disease symptoms after exposure to...

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new strategy to help people with obstructive sleep apnea.

News All Time

Treprostinil Turns Heads in Promising IPF Study

Data from the TETON-1 phase 3 trial showed even greater response over TETON-2 study.

Ketamine Tied to Rapid Relief of Depression Symptoms

A meta-analysis links intravenous ketamine with significant reductions in suicidal thoughts and depressive symptoms within hours of treatment.

Talking Bot Wins Over Patients and Docs in Ophthalmology

A voice-based generative AI assistant designed for patient education in ophthalmology is well received by patients, healthcare professionals, and practice managers, according to a qualitative study.

CDC Offers Hantavirus Guidance, Says Risk Is Extremely Low

Forty-one Americans considered at higher risk are being monitored, while public health labs scramble to validate PCR assays that can detect infection before symptoms start.

ECMO Cannulation Improves Outcomes as Lung Transplant Bridge

Clinical advantage was notable in older patients.

'Deadly Mix' Puts Patients at Risk, RCN Congress Hears

A quarter of nurses say staffing on their last shift was so far below what was needed that patients and staff faced a high risk of harm, an RCN survey shows.

Flawed Tests and Funerals Allowed Ebola to Spread Undetected, Sources Say

By the time health officials confirmed new Ebola infections in eastern Democratic Republic of Congo last week, the total number of suspected cases meant the outbreak was...

American Doctor Has Ebola, Will Be Transferred for Care

Two other physicians — including the doctor’s wife — were potentially exposed, along with their four children.

FDA Psychiatry Roundup: April 2026

A monthly snapshot of FDA activity involving therapies used in the prevention and treatment of psychiatric conditions.

Is Ketamine for Depression Moving Too Fast on Weak Data?

Ketamine has been hailed as a fast-acting, effective treatment for major depression. But new research questions whether the drug lives up to its hype.

IA Thrombolysis After Thrombectomy: More Uncertainty

The TECNO trial finds no clear reperfusion benefit from intra-arterial thrombolysis after thrombectomy in acute ischemic stroke, raising fresh doubts about the strategy.

Aging in Hospital Medicine: How to Retain Older Hospitalists

The schedule and demanding nature of the job make hospitalist jobs more difficult as you age. Some systems are trying to help.

Soccer-Study Warns Of Dangerous Heat At 2026 World Cup as Climate Risks Grow

Football's global players' union renewed concerns on Thursday about heat at the 2026 World Cup after scientists warned the likelihood of dangerous temperatures for players...

Is Flare Prophylaxis Always Needed When Starting Gout Drugs?

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

CMV Infection in Early Pregnancy Tied to Autism Risk in Kids

Children with congenital cytomegalovirus infection may experience complications such as autism and hearing loss if their mothers have a first-time infection during the first trimester.

Medicine Through Film: 10 Classics for Clinicians

Ten cinematic classics trace medicine’s moral, social, and scientific dilemmas — a curated watchlist that highlights storytelling, stigma, and a call for female leads.

Recommended News For You

A computer-aided diagnostic system for improved detection of breast cancer.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.

Genetics and therapy type determine second cancer risk after childhood treatment, study finds

GuCS: Genitourinary Cancers Symposium

Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies

CAR T cells improve patients' quality of life: a study

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

Recommended Articles For You

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access 

Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells 

The Pros and Cons of Steroid Therapy for ITP 

New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

2.

MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information

3.

Prostate cancer mortality is significantly reduced when docetaxel is used.

4.

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

5.

Medical Journal March 28, 2023

1.

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies

2.

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management

3.

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

4.

Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After 

5.

Nuclear Medicine's Role in Battling Women's Cancers

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

4.

Efficient Management of First line ALK-rearranged NSCLC - Part V

5.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot